FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Biostax's Trailing 12-Month Free Cash Flow is $0.14 Mil, and Market Cap is $0.02 Mil. Therefore, Biostax's FCF Yield % for today is 800.00%.
The historical rank and industry rank for Biostax's FCF Yield % or its related term are showing as below:
BTAX'
s FCF Yield % Range Over the Past 10 Years
Min: -486842.11 Med: -29.2 Max: 800
Current: 800
During the past 12 years, the highest FCF Yield % of Biostax was 800.00%. The lowest was -486842.11%. And the median was -29.20%.
BTAX's FCF Yield % is ranked better than 99.87% of 1497
companies
in the Biotechnology industry
Industry Median: -15.53
vs BTAX: 800.00
The historical data trend for Biostax's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Biostax's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biostax's FCF Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Biostax's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Biostax's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biostax FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Biostax FCF Yield % Related Terms
Thank you for viewing the detailed overview of Biostax's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Biostax Corp is a biotechnology company utilizing the Biostax Development Engine, is a developer and marketer of pharmaceutical, biotechnology and MedTech products that have a well-defined path to market. The company is focused on driving the development and commercialization of proprietary mechanisms to prevent, intercept and improve these diseases at affordable cost. It is a therapeutic and health tech agnostic, constantly seeking assets with low acquisition costs and high growth opportunities having significant clinical and commercial potential.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BTAX has been successfully added to your 